Amneal to Present at the UBS Global Healthcare Conference

Monday, May 14, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

BRIDGEWATER, N.J., May 14, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced

that Rob Stewart, President and Chief Executive Officer of Amneal, will present at the UBS Global Healthcare Conference on Monday, May 21, 2018 at 8:30 a.m. Eastern Time.

To

access a live webcast of the presentation, visit Amneal's Investor Relations Web site at https://investors.amneal.com/Investor-Relations. The webcast can also be accessed at the following URL:

https://cc.talkpoint.com/ubsx001/052118a_as/?entity=65_KK0FRJD

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,500 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company markets a portfolio of branded pharmaceutical products through its Impax Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

Contact:                                                                    Mark Donohue  Investor Relations and Corporate Communications        (215) 558-4526                                                               www.amneal.com                                                      

Cision View original content:http://www.prnewswire.com/news-releases/amneal-to-present-at-the-ubs-global-healthcare-conference-300647548.html

SOURCE Amneal Pharmaceuticals, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store